Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Article
Osteoporosis Drug Approval Highlights AJPB Week in Review
Author(s):
Top news of the week from The American Journal of Pharmacy Benefits.
5. FDA Grants Breakthrough Therapy, Fast Track Designations to Narcolepsy Treatment
The FDA has granted Harmony Biosciences a Breakthrough Therapy designation for pitolisant, an investigational therapy for the treatment of cataplexy in patients with narcolepsy.
Related Videos
Related Content
